Mike Doustdar, new CEO of Ozempic maker, Novo Nordisk discusses his strategy for the future of the company. Walmart employee ...

Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

“Lifestyle changes are associated with modest improvements in sperm motility and morphology, even though the amount of weight ...

This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...

Obesity drugs have become an increasingly popular method of weight loss but most are not covered by insurance for that ...

Earlier this week, Ashley Dupré lashed out at Burke for giving her stepdaughter a lower score than the other judges.

Alix Earle’s stepmom, Ashley Dupré, responded to Burke’s scoring of Earle and Val Chmerkovskiy by saying “go take more ...

The Rise Of GLP-1 Drugs In just three years, drugs like Ozempic have reshaped how society views the body. They reignited a ...

Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock are in focus as the companies are nearing to strike U.S. pricing deals for ...

A MAJOR review has pitted three blockbuster fat jabs against each other – comparing weight lost and how long users were able ...

An Institute for Clinical and Economic Review report concluded that the GLP-1 drugs tirzepatide and semaglutide (Ozempic, ...

Novo Nordisk said the overhaul resulted in one-off costs of about DKK 9 billion in 2025, including DKK 5 billion in severance ...